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ABSTRACT
INTRODUCTION: Transient ischaemic attacks (TIAs) indicate high risk for stroke and rapid manage-
ment reduces stroke burden. Rapid specialist access to initiate timely management is often challenging to 
achieve.
AIM: To assess the feasibility of implementing a TIA/Stroke electronic decision support (EDS) tool 
intended to aid general practitioners (GPs) in the timely management of TIAs.
METHODS: An eight-week pilot provided access to the TIA/Stroke EDS to selected GPs in the MidCen-
tral district, with subsequent patient record review and a post-pilot user satisfaction survey.
RESULTS: Eleven patients from eight practices were entered into the tool and when EDS-rendered 
advice was followed, diagnosis was accurate and management was in accordance with New Zealand TIA 
guidelines. No adverse outcomes resulted and user feedback was positive.
DISCUSSION: Results indicate that wider implementation of the TIA/Stroke EDS tool is feasible.
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Introduction
Stroke is the second most common cause of death 
worldwide and the most common cause of long-
term adult disability in developed countries.1,2 
Transient ischaemic attacks (TIA) identify people 
at high risk of stroke. This risk is greatest in the 
first 48 hours and then decreases over time. The 
key intervention that reduces subsequent stroke 
is same-day specialist review and initiation of 
best medical therapy at first point of contact,3,4 
which has been associated with an 80% reduction 
in 90-day stroke risk from 10.3% to 2.1%.4
Providing 24-hour, seven-days-a-week rapid 
access to stroke specialists is a challenge through-
out New Zealand and in particular in the smaller-
sized district health boards (DHBs). To circum-
vent the problem of limited or delayed access to 
hospital specialist assessment, the MidCentral 
Stroke Service, in collaboration with the Mid-
Central DHB, and the Best Practice Advocacy 
Centre Inc. (BPAC Inc.), developed a novel elec-
tronic decision support (EDS) tool to aid general 
practitioners (GPs) in diagnosing, triaging, and 
treating patients appropriately and expediently. 
The tool is based primarily on the New Zealand 
Guideline for the Assessment and Management of 
People with Recent Transient Ischaemic Attack5 
and its main objective is to prompt initiation of 
best medical therapy at first point of contact in 
the community, rather than awaiting potentially 
delayed specialist review at the hospital. In order 
to support rapid work-up in the community, GPs 
also gain access to relevant diagnostics (e.g. head 
CT and carotid ultrasound) if deemed appropriate 
by the EDS tool. The tool is web-based, main-
tained by BPAC Inc., and requires access to the 
MedTech32 practice management system.
The purpose of this pilot was to assess the fea-
sibility of implementing the TIA/Stroke EDS in 
the MidCentral DHB primary care sector prior to 
a district-wide launch. 
Methods
At the time of the pilot there were 32 practices in 
the MidCentral District using MedTech32. This 
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practices and pilot practices were chosen based on 
three factors: adequate numbers of GPs, current 
capability to access best practice EDS modules, 
and an overall representative patient mix of the 
MidCentral population. Practices were located in 
the provincial centre of Palmerston North and 
the smaller nearby town of Feilding. One practice 
serves a predominantly Maori population. Practic-
es were of median size ranging from two to five 
GPs per practice. 
The tool itself consists of a web-based data entry 
form requesting information about the presenting 
symptoms and a brief examination. Some entry 
fields are self-populated through data extraction 
from the practice management system. Entering 
patient data takes approximately three to five 
minutes. 
The tool then runs the information through an 
algorithm with three main possible diagnostic 
outcomes: (a) stroke, (b) TIA, or (c) ‘non-straight-
forward neurological presentation.’ 
The first two are further subdivided by risk 
category and anatomic localisation. Lastly, several 
additional stipulations to ‘diagnosis and triage’ 
advice are provided if (a) the patient is young 
(<60 years), (b) presentation includes atypical 
symptoms, or (c) the patient is either terminally 
ill or severely demented. 
Triage advice is given in accordance with the 
New Zealand TIA guidelines5 and depends on 
the diagnosis, localisation, and risk category. If 
several management options are acceptable, then 
the GP is presented with options varying in 
degree of specialist support. 
Two weeks prior to the pilot period, an educa-
tional session was offered to participating GPs 
and their practice nurses covering TIA manage-
ment principles and instructions as to how to 
use the tool. The EDS was made available to 
participating practices for a total of eight weeks 
(27/7/09–25/9/09). Participating GPs were asked 
to enter all potential TIA/stroke patients during 
the eight-week pilot period. At the end of the 
eight-week period, relevant patient data was 
reviewed through access to centralised records 
captured by BPAC Inc. as well as by review of 
relevant GP and hospital records. In addition, 
participating GPs were interviewed using a stand-
ardised questionnaire.
National Ethics Committee research ethics ap-
proval was not required for the evaluation of the 
TIA/Stroke EDS roll-out in the MidCentral Dis-
trict. This non-experimental and observational 
‘study’ was classed as a clinical audit. 
Results
Throughout the pilot period eight GPs entered 11 
patients into the EDS tool seeking management 
advice. 
In nine of these patients, the advice rendered 
by the EDS was followed by the treating GPs 
and this resulted in two emergency department 
referrals, three TIA clinic referrals, and four 
community ‘work-ups’ by GPs. In all nine cases, 
the initial diagnosis made by the EDS was later 
confirmed as appropriate by a stroke specialist 
and TIA triage and management occurred in ac-
cordance with the New Zealand TIA guidelines.5 
None of the patients experienced any adverse 
outcomes relating to EDS use.
In two cases, GPs did not utilise the EDS tool 
appropriately and subsequent management 
was not in accordance with New Zealand TIA 
guidelines. In the first, the GP started to use the 
EDS tool but aborted use before reaching the 
‘advice’ screen. Thus the GP managed the patient 
‘on his own’ without benefiting from EDS use. 
This patient was diagnosed by the GP as having 
a TIA; however, this diagnosis was later deemed 
incorrect by a specialist. Had the GP continued 
on to the EDS advice screen, the EDS tool would 
WHAT GAP THIS FILLS
What we already know: Transient ischaemic attacks (TIAs) indicate high 
risk for stroke and rapid management reduces stroke burden. Rapid specialist 
access to initiate timely management is often challenging to achieve.
What this study adds: A TIA/Stroke electronic decision support tool was 
created to facilitate early initiation of best medical management by general 
practitioners (GPs) to circumvent need for rapid specialist access in all cases. 
This pilot suggests that the use of this tool by GPs is feasible and safe.140  VOLUME 5 • NUMBER 2 • JUNE 2013  JOURNAL OF PRIMARY HEALTH CARE
have informed the GP that a diagnosis of TIA 
was in fact unlikely, which may have led to ar-
riving at the correct diagnosis sooner. The second 
patient’s data was entered correctly into the EDS 
tool and was correctly diagnosed by the tool as 
having suffered a stroke rather than a TIA. How-
ever, despite the EDS advising the GP to refer the 
patient to the Accident & Emergency Department 
(A&E) for urgent specialist review, general prac-
tice–based management continued. This led to 
inappropriate delays in diagnostics and precluded 
timely access to rehabilitation services. The au-
thor is aware of one additional TIA patient who 
presented to this cohort of GPs during the pilot 
period who was not entered into the EDS because 
of local IT difficulties.
According to the post-pilot questionnaire, all 
participating GPs who had used the tool were sat-
isfied with the TIA/Stroke EDS software and had 
no major concerns regarding user-friendliness, 
time required to enter data, or the overall advice 
given by the tool. A few minor issues were raised, 
including a request to allow the GP more override 
options if the advice given by the tool appeared 
to be inappropriate. Other comments included a 
mention that some medications were not recog-
nised by the EDS and a request to add a free-text 
box to enter additional information to appear on 
the referral form. In addition, some GPs voiced 
concerns that A&E staff might turn down refer-
rals for patients with TIA as they would not be 
deemed urgent enough by frontline hospital staff. 
However, those GPs who in fact used an EDS-
generated A&E referral to send a patient to the 
A&E reported that having used the tool actually 
helped the A&E referral process because it lent 
extra credence to the GP’s assessment.
Discussion
TIAs are medical emergencies requiring urgent 
intervention in high-risk patients and this novel 
TIA/Stroke EDS tool is intended to improve ap-
propriateness and urgency of care. However, prior 
to launching this tool it was important to ensure 
that there were no significant risks to patients 
associated with software use.
Overall, this pilot did not identify any areas of 
unacceptable risk associated with TIA/Stroke 
EDS use that would preclude wider implementa-
tion. In addition, participant feedback was posi-
tive and suggested that the tool was user-friendly 
and seen as potentially beneficial by treating GPs. 
The request to allow GPs more override options 
is a slightly difficult one. On the one hand, if 
sufficient flexibility is not allowed, clinicians 
may see the tool as impinging on their autonomy 
and may simply not use it. On the other hand, 
the pilot data indicated that when GPs did not 
follow the advice given by the EDS, management 
was less appropriate. To compromise, some ad-
ditional override options were added to the EDS 
following the pilot; however, diagnostic access 
continues to be available only for patients deemed 
to require them by the EDS tool. In addition, GPs 
have to enter a reason for overriding the advice 
and are continuously reminded that they are 
veering away from the suggested and guideline-
based treatment plan.
In conclusion, this pilot was judged sufficient to 
indicate acceptable usability and safety and the 
TIA/Stroke EDS has been launched in the Mid-
Central District. Based on this pilot and prelimi-
nary results from district-wide post-implemen-
tation evaluations, the Health Research Council 
has funded a randomised controlled trial compar-
ing EDS versus non-EDS assisted TIA manage-
ment in a number of New Zealand DHBs. This 
trial (FASTEST Trial: ACTRN12611000792921) 
is currently underway to assess feasibility of na-
tionwide launch of this software tool and results 
will be available next year.
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